組織検査と細胞診の市場- 世界の産業規模、シェア、動向、機会、予測、2018年～2028年検査タイプ別、製品別、用途別、地域別、競合市場別分析

世界の組織学・細胞学市場は、2022年に157億4,000万米ドルの評価額に達し、年間平均成長率（CAGR）14.67％で力強い成長を遂げ、2028年には311億6,000万米ドルに達すると予測されています。

細胞学と組織学は、生命科学の一分野であり、生体内の細胞、組織、およびそれらの微視的解剖学の構造、機能、理解に焦点を当てています。これらの分野は、動物や植物の組織や細胞を、特に顕微鏡レベルで理解することに貢献し、様々な応用に役立っています。

主な市場促進要因

がん罹患率の増加

がんの有病率の増加は、世界の組織学・細胞学市場の成長に大きく影響しています。組織学と細胞学は、がんの診断や様々な疾患を細胞レベルで理解する上で重要な役割を果たしています。がん患者の増加に伴い、正確な診断技術に対する需要が不可欠になっています。これらの技術は、顕微鏡下で組織サンプルや細胞を検査することにより、様々なタイプのがんの診断を支援します。がん検診や診断の増加に伴い、組織学や細胞学のサービスや機器に対する需要も高まっています。

研究開発活動の拡大

研究開発（R&D）の努力は組織学と細胞学の技術革新を推進し、診断と調査方法の精度と信頼性を高める。研究開発を通じて開発された高度なイメージング技術、自動化ソリューション、デジタル病理システムは、診断能力の向上により市場開拓に貢献しています。研究開発活動は、診断精度の向上、新しい染色法、分子マーカー、画像化技術の開発に重点を置いており、これらはより正確な診断につながり、これらのサービスの需要を促進しています。

個別化医療への注力

組織・細胞診サービスに対する需要は、遺伝子および分子情報を分析する分子診断学に依存する個別化医療の文脈で増加します。これらの技術は特定の遺伝子変異や変化を特定するのに役立ち、治療方針の決定を導き、市場の成長に寄与します。組織学と細胞学は、患者固有の疾患特性に基づいて治療戦略を調整するために不可欠な情報を提供し、これらの技術に対する需要を促進しています。

主な市場課題

技術の複雑さとコスト

高度な組織学・細胞学技術は、機器、ソフトウェア、トレーニングに多額の投資を必要とすることが多く、リソースが限られている施設にとっては障壁となり得る。メンテナンスコストや既存システムとの統合の課題も、技術導入の妨げとなります。

検査室の人材不足

熟練した検査専門家の不足は、診断や検査結果の報告の遅れにつながり、患者ケアや技術革新に影響を与えます。労働力不足は、研究開発、新技術導入の能力を制限する可能性があります。

主要市場動向

リキッドバイオプシーと循環バイオマーカー

体液中のバイオマーカーを分析するリキッドバイオプシーの出現は、組織診および細胞診サービスの需要に寄与しています。これらの生検は疾患の早期発見を可能にし、従来の組織学的・細胞学的手法による検証を必要とします。

マルチオミクス・アプローチ

複数のレベルで同時に病気を研究するマルチオミクス・アプローチは、組織診と細胞診の需要を高めています。これらの技術は疾患メカニズムに対する包括的な洞察を提供し、組織診と細胞診はマルチオミクスデータから得られた知見を検証します。

セグメント別の洞察

検査の種類

細胞診分野は、疾患の早期発見におけるその役割から、大幅な成長が見込まれています。パップスメアや細針吸引などの技術は、異常な細胞変化を特定するのに役立ち、タイムリーな介入と患者の転帰改善につながります。

応用分野

組織学と細胞診は、薬物標的の検証、薬物の安全性の評価、個別化医療の実現に極めて重要であるため、創薬・薬剤設計分野が市場を独占しています。これらの技術は、分子間相互作用や組織特異的効果に関する洞察を提供します。

地域別洞察

北米は、先進的なヘルスケアシステム、研究機関、規制の枠組みにより市場をリードしています。研究努力の集中と明確な規制環境が技術革新と技術導入を促し、市場成長を牽引しています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 組織学と細胞学の世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別（組織学、細胞学）
  • 製品別（装置・分析ソフトウェアシステム、消耗品・試薬）
  • 用途別（創薬・設計、臨床診断、調査）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2022年）
• 市場マップ
  • 検査タイプ別
  • 製品別
  • 用途別
  • 地域別

第6章 北米組織学・細胞学市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の組織学・細胞学市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋組織学・細胞学市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の組織学・細胞学市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの組織学・細胞学市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 組織学と細胞学の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Product Offerings
• Recent Developments
• Financials（As Reported）
• Key Personnel
• SWOT Analysis
  • Hologic, Inc.
  • F Hoffmann-La Roche AG.
  • Abbott Laboratories Inc.
  • Becton Dickinson & Co.
  • Danaher Corporation.
  • Merck KGaA.
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation.
  • Trivitron Healthcare.
  • Koninklijke Philips N.V.

第16章 戦略的提言

The Global Histology and Cytology Market reached a valuation of USD 15.74 billion in 2022 and is expected to experience robust growth with a Compound Annual Growth Rate (CAGR) of 14.67% and expected to reach USD 31.16 Billion by 2028. Cytology and histology are branches of life science that focus on the structure, function, and understanding of cells, tissues, and their microscopic anatomy in living organisms. These fields contribute to the comprehension of animal and plant tissues and cells, particularly at the microscopic level, aiding in various applications.

Key Market Drivers

Increase in Cancer Prevalence

The rising prevalence of cancer significantly impacts the growth of the Global Histology and Cytology Market. Histology and cytology play a crucial role in diagnosing cancer and understanding various diseases at the cellular level. With the increasing number of cancer cases, the demand for accurate diagnostic techniques becomes vital. These techniques assist in diagnosing different types of cancers by examining tissue samples and cells under a microscope. As cancer screening and diagnostics increase, the demand for histology and cytology services and equipment also rises.

Growing Research and Development Activities

Research and development (R&D) efforts drive innovation in histology and cytology, enhancing the accuracy and reliability of diagnostic and research processes. Advanced imaging techniques, automation solutions, and digital pathology systems developed through R&D contribute to the market growth by offering improved diagnostic capabilities. R&D activities focus on improving diagnostic accuracy and developing new staining methods, molecular markers, and imaging technologies, which lead to more accurate diagnoses and drive demand for these services.

Focus on Personalized Medicine

The demand for histology and cytology services increases in the context of personalized medicine, which relies on molecular diagnostics to analyze genetic and molecular information. These techniques aid in identifying specific genetic mutations and alterations, guiding treatment decisions and contributing to market growth. Histology and cytology provide essential information for tailoring treatment strategies based on a patient's unique disease characteristics, driving demand for these techniques.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant investments in equipment, software, and training, which can pose barriers for institutions with limited resources. Maintenance costs and integration challenges with existing systems can also hinder technology adoption.

Laboratory Workforce Shortages

A shortage of skilled laboratory professionals can lead to delays in diagnosing and reporting test results, impacting patient care and innovation. Workforce shortages can limit the capacity for research, development, and the adoption of new technologies.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

The emergence of liquid biopsies, which analyze biomarkers in bodily fluids, contributes to the demand for histology and cytology services. These biopsies enable early disease detection and require validation through traditional histological and cytological methods.

Multi-Omics Approaches

Multi-omics approaches that study diseases at multiple levels simultaneously enhance the demand for histology and cytology. These techniques provide comprehensive insights into disease mechanisms, and histology and cytology validate findings from multi-omics data.

Segmental Insights

Type of Examination

The cytology segment is expected to witness substantial growth due to its role in early disease detection. Techniques like Pap smears and fine-needle aspirations aid in identifying abnormal cellular changes, leading to timely interventions and improved patient outcomes.

Application

The Drug Discovery & Designing segment dominates the market as histology and cytology are crucial for validating drug targets, assessing drug safety, and enabling personalized medicine. These techniques provide insights into molecular interactions and tissue-specific effects.

Regional Insights

North America leads the market due to its advanced healthcare systems, research institutions, and regulatory framework. The concentration of research efforts and a clear regulatory environment encourage innovation and technology adoption, driving market growth.

Key Market Players

• Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Histology and Cytology Market, By Type of Examination:

• Histology
• Cytology

Histology and Cytology Market, By Product:

• Instruments and Analysis Software System
• Consumable and Reagents

Histology and Cytology Market, By Application:

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology and Cytology Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

• Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type Of Examination (Histology, Cytology)
  • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Type of Examination
  • 5.3.2 By Product
  • 5.3.3 By Application
  • 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type Of Examination (Histology, Cytology)
  • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Histology and Cytology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Examination
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Histology and Cytology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Examination
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Histology and Cytology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Examination
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type Of Examination (Histology, Cytology)
  • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Histology and Cytology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Examination
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Histology and Cytology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Examination
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Histology and Cytology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Examination
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Histology and Cytology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Examination
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Histology and Cytology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Examination
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type Of Examination (Histology, Cytology)
  • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Histology and Cytology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Examination
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Histology and Cytology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Examination
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Histology and Cytology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Examination
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Histology and Cytology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Examination
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Histology and Cytology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Examination
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type Of Examination (Histology, Cytology)
  • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Histology and Cytology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Examination
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Histology and Cytology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Examination
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Histology and Cytology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Examination
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type Of Examination (Histology, Cytology)
  • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Histology and Cytology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Examination
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Type
      • 10.3.2.2.2. By Type of Examination
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Histology and Cytology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Examination
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Hologic, Inc.
  • 15.6.2 F Hoffmann-La Roche AG.
  • 15.6.3 Abbott Laboratories Inc.
  • 15.6.4 Becton Dickinson & Co.
  • 15.6.5 Danaher Corporation.
  • 15.6.6 Merck KGaA.
  • 15.6.7 Thermo Fisher Scientific, Inc.
  • 15.6.8 Sysmex Corporation.
  • 15.6.9 Trivitron Healthcare.
  • 15.6.10 Koninklijke Philips N.V.

16. Strategic Recommendations